Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-akt | 11 | 2022 | 331 | 2.530 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2022 | 118 | 2.230 |
Why?
|
| Carcinogenesis | 7 | 2021 | 124 | 1.800 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2022 | 10 | 1.610 |
Why?
|
| Repressor Proteins | 6 | 2019 | 183 | 1.170 |
Why?
|
| Nuclear Proteins | 5 | 2018 | 271 | 0.980 |
Why?
|
| Histones | 2 | 2022 | 111 | 0.950 |
Why?
|
| Arginine | 2 | 2022 | 102 | 0.940 |
Why?
|
| Ubiquitination | 7 | 2018 | 85 | 0.930 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2022 | 284 | 0.860 |
Why?
|
| Neoplasms | 10 | 2021 | 1667 | 0.820 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2020 | 32 | 0.810 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 194 | 0.760 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 37 | 0.730 |
Why?
|
| HEK293 Cells | 10 | 2021 | 326 | 0.720 |
Why?
|
| Ras Homolog Enriched in Brain Protein | 1 | 2020 | 2 | 0.710 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2020 | 3 | 0.710 |
Why?
|
| Prostatic Neoplasms | 5 | 2018 | 778 | 0.710 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 102 | 0.690 |
Why?
|
| Multiprotein Complexes | 6 | 2017 | 56 | 0.650 |
Why?
|
| DNA Damage | 4 | 2022 | 190 | 0.640 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 307 | 0.630 |
Why?
|
| DNA Repair Enzymes | 2 | 2015 | 53 | 0.630 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 328 | 0.610 |
Why?
|
| Signal Transduction | 10 | 2021 | 2689 | 0.590 |
Why?
|
| Cell Proliferation | 7 | 2021 | 1174 | 0.580 |
Why?
|
| Phosphorylation | 12 | 2022 | 1200 | 0.530 |
Why?
|
| Genomic Instability | 2 | 2015 | 41 | 0.530 |
Why?
|
| Mice, Nude | 6 | 2021 | 294 | 0.510 |
Why?
|
| Methylation | 4 | 2022 | 56 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2022 | 214 | 0.480 |
Why?
|
| Sirolimus | 1 | 2015 | 118 | 0.480 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 700 | 0.480 |
Why?
|
| Trans-Activators | 1 | 2015 | 237 | 0.470 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 940 | 0.440 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 615 | 0.440 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 1851 | 0.420 |
Why?
|
| DNA Repair | 3 | 2018 | 127 | 0.410 |
Why?
|
| HeLa Cells | 7 | 2021 | 237 | 0.400 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 7 | 2022 | 14 | 0.400 |
Why?
|
| Mutation | 8 | 2021 | 1213 | 0.380 |
Why?
|
| Apoptosis | 3 | 2017 | 1641 | 0.350 |
Why?
|
| HCT116 Cells | 5 | 2021 | 63 | 0.340 |
Why?
|
| Enzyme Activation | 6 | 2021 | 791 | 0.320 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2018 | 16 | 0.310 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 331 | 0.270 |
Why?
|
| Protein Interaction Domains and Motifs | 5 | 2018 | 57 | 0.270 |
Why?
|
| Amino Acid Sequence | 3 | 2015 | 1083 | 0.250 |
Why?
|
| Humans | 24 | 2021 | 68618 | 0.250 |
Why?
|
| Cullin Proteins | 4 | 2018 | 14 | 0.240 |
Why?
|
| Animals | 14 | 2021 | 20881 | 0.240 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 1447 | 0.240 |
Why?
|
| Protein Binding | 4 | 2021 | 1027 | 0.240 |
Why?
|
| Cell Movement | 2 | 2018 | 630 | 0.230 |
Why?
|
| Amino Acid Motifs | 2 | 2021 | 77 | 0.230 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 1033 | 0.210 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2019 | 33 | 0.210 |
Why?
|
| Proteolysis | 3 | 2021 | 97 | 0.210 |
Why?
|
| Heterografts | 2 | 2020 | 70 | 0.200 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 18 | 0.200 |
Why?
|
| Polyubiquitin | 2 | 2018 | 3 | 0.200 |
Why?
|
| Biocatalysis | 1 | 2021 | 23 | 0.190 |
Why?
|
| Oncogenes | 1 | 2021 | 71 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 332 | 0.180 |
Why?
|
| Mice | 8 | 2020 | 8474 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 304 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 6 | 0.180 |
Why?
|
| Neurofibromin 2 | 1 | 2020 | 10 | 0.180 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 1536 | 0.180 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 80 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 41 | 0.170 |
Why?
|
| Cell Membrane | 1 | 2021 | 525 | 0.170 |
Why?
|
| Gene Editing | 1 | 2020 | 33 | 0.170 |
Why?
|
| Cdh1 Proteins | 1 | 2019 | 1 | 0.170 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2019 | 2 | 0.170 |
Why?
|
| Organ Size | 1 | 2020 | 242 | 0.170 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 434 | 0.170 |
Why?
|
| G1 Phase | 1 | 2019 | 42 | 0.170 |
Why?
|
| Protein Methyltransferases | 1 | 2019 | 5 | 0.170 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 44 | 0.160 |
Why?
|
| DNA Ligases | 2 | 2015 | 6 | 0.160 |
Why?
|
| DNA Ligase ATP | 2 | 2015 | 3 | 0.160 |
Why?
|
| Cadherins | 1 | 2019 | 93 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 108 | 0.160 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2018 | 6 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2019 | 230 | 0.160 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 35 | 0.150 |
Why?
|
| Culture Media, Conditioned | 1 | 2018 | 78 | 0.150 |
Why?
|
| Lysine | 1 | 2018 | 96 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 216 | 0.150 |
Why?
|
| Phosphothreonine | 2 | 2014 | 5 | 0.150 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2017 | 6 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 89 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 299 | 0.150 |
Why?
|
| Endopeptidases | 1 | 2017 | 52 | 0.150 |
Why?
|
| Stem Cells | 1 | 2018 | 248 | 0.140 |
Why?
|
| Cdc20 Proteins | 1 | 2016 | 2 | 0.140 |
Why?
|
| Tumor Hypoxia | 1 | 2016 | 3 | 0.140 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 13 | 0.140 |
Why?
|
| Ubiquitin | 1 | 2017 | 74 | 0.140 |
Why?
|
| Proline | 1 | 2016 | 52 | 0.140 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1070 | 0.130 |
Why?
|
| Retinoblastoma Protein | 1 | 2016 | 75 | 0.130 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2015 | 7 | 0.130 |
Why?
|
| Disease Progression | 2 | 2018 | 1038 | 0.130 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2015 | 6 | 0.130 |
Why?
|
| Etoposide | 1 | 2015 | 64 | 0.130 |
Why?
|
| Homologous Recombination | 1 | 2015 | 13 | 0.130 |
Why?
|
| DNA | 1 | 2018 | 597 | 0.130 |
Why?
|
| DNA End-Joining Repair | 1 | 2015 | 7 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 88 | 0.130 |
Why?
|
| Female | 7 | 2021 | 38074 | 0.120 |
Why?
|
| Liver | 1 | 2020 | 1118 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 369 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2015 | 215 | 0.110 |
Why?
|
| Myocardium | 1 | 2020 | 1204 | 0.110 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2019 | 24 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2017 | 753 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 468 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2014 | 312 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 170 | 0.100 |
Why?
|
| Male | 8 | 2021 | 37321 | 0.090 |
Why?
|
| Tumor Burden | 2 | 2018 | 132 | 0.070 |
Why?
|
| Binding Sites | 2 | 2019 | 631 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2018 | 546 | 0.060 |
Why?
|
| Transfection | 2 | 2016 | 782 | 0.060 |
Why?
|
| Cell Line | 2 | 2018 | 1752 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1745 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 122 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2021 | 161 | 0.050 |
Why?
|
| Computational Biology | 1 | 2021 | 190 | 0.040 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2019 | 2 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 65 | 0.040 |
Why?
|
| Plicamycin | 1 | 2019 | 2 | 0.040 |
Why?
|
| Sf9 Cells | 1 | 2019 | 3 | 0.040 |
Why?
|
| Spodoptera | 1 | 2019 | 21 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2019 | 122 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 82 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 80 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 4655 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 50 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 48 | 0.040 |
Why?
|
| Azepines | 1 | 2017 | 15 | 0.040 |
Why?
|
| MTOR Associated Protein, LST8 Homolog | 1 | 2017 | 1 | 0.040 |
Why?
|
| Thalidomide | 1 | 2017 | 24 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.040 |
Why?
|
| Triazoles | 1 | 2017 | 43 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1692 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 132 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2017 | 254 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2017 | 99 | 0.040 |
Why?
|
| Diamines | 1 | 2016 | 9 | 0.040 |
Why?
|
| Cyclopentanes | 1 | 2016 | 15 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2018 | 308 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 532 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2016 | 41 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2017 | 130 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 852 | 0.030 |
Why?
|
| Carbamates | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cyclin D | 1 | 2016 | 12 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2673 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2016 | 28 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 209 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2016 | 36 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 260 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 291 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 230 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 215 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 123 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2016 | 178 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 128 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 266 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2015 | 8 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 78 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 12 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 213 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 165 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2015 | 155 | 0.030 |
Why?
|
| Cyclin A2 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Phosphoserine | 1 | 2014 | 14 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 682 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 14 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1174 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 40 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 659 | 0.030 |
Why?
|
| Models, Biological | 1 | 2014 | 981 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1173 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2550 | 0.020 |
Why?
|